Skip to main content

Nvdium205 published today

Latest Technology Finance Media Earnings

Search

1
2
3
4
5
6
7
8
9
10

NEWSLETTER

Get the signals worth reading in your inbox

Email address

By subscribing, you agree to our privacy policy.

NvdiumMake valuable technology information easier to discover.© 2026 Nvdium

About Copyright PrivacyComplaints

Biopharma firm AusperBio secures $120m Series C funding · Nvdium

←Back to feed

Home/Traditional media/Article

Biopharma firm AusperBio secures $120m Series C funding

DealStreetAsia · Home·Published Sep 3, 2026, 12:45 AM·0 reads

Biopharma firm AusperBio secures $120m Series C funding cover image

The new round brought AusperBio’s fundraising total since 2024 to over $340 million.

Read the original at dealstreetasia.com Open original ↗

Share this signal

Copyright belongs to the original author and source. Nvdium provides aggregation and reading navigation only.

Related articles

Abel: Two ways Berkshire hopes to cash in on AI
This enhanced geothermal project aims to unlock gigawatts of power to fuel the data center boom
Missouri asks Supreme Court to revive Republican-drawn congressional map
Trump’s state capitalism comes to the oil industry with his unprecedented Venezuela deal
From ‘mystery vacations’ to hostels, budget travelers get thrifty as prices rise
Goldman Sachs says buy the dip in these five stocks before it's too late